Insider Transactions Reported by 16 Insiders of FILANA THERAPEUTICS, INC.

Symbol
SAVA on Nasdaq
Location
Austin, TX

Insiders trading volume in the past year

FILANA THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sanford Robertson Director $25,241,772 16 May 2024
Richard Barry President & CEO, Director $12,711,045 +$1,166,904 +10% 20 Nov 2025
Robert Christopher Cook Chief Operating & Legal Office $1,726,939 +$39,940 +2.4% 30 Sep 2025
Freda Nassif Chief Business Officer $1,687,000 17 Apr 2025
James William Kupiec Chief Medical Officer $1,687,000 29 Nov 2024
Jaren Landen Chief Clinical Dev. Officer $1,433,950 18 Nov 2024
Remi Barbier President & CEO, Director $843,500 20 May 2024
Robert Z. Gussin Director $253,050 23 May 2025
Robert Eugene Anderson Jr. Director $193,640 +$24,940 +15% 24 Nov 2025
Michael J. O Donnell Director $168,700 23 May 2025
Pierre Gravier Director $168,700 23 May 2025
Claude Nicaise Director $168,700 23 May 2025
Patrick J. MD Scannon PhD Director $168,700 23 May 2025
Eric J. Schoen Chief Financial Officer $44,390 17 Apr 2025
Nadav Friedmann Chief Medical Officer, Director $2,495 31 Dec 2022
Dawn Carter Bir Director 21 Oct 2025

Recent Insider Transactions by Companies or Individuals for FILANA THERAPEUTICS, INC.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Robert Eugene Anderson Jr. SAVA Common Stock Purchase $24,940 $2.90 8,600 8,600 24 Nov 2025 Direct
Richard Barry SAVA Common Stock Purchase 19% $414,000 $2.76 150,000 938,060 20 Nov 2025 By Trust
Richard Barry SAVA Common Stock Purchase 10.3% $201,809 $2.75 73,385 788,060 19 Nov 2025 By Trust
Dawn Carter Bir SAVA Stock Option (Right to Buy) Award 53,000 53,000 21 Oct 2025 Direct
Robert Christopher Cook SAVA Common Stock Purchase $39,940 $2.91 13,725 13,725 30 Sep 2025 Direct
Richard Barry SAVA Common Stock Purchase 1.01% $16,352 $2.28 7,172 714,675 22 Sep 2025 By Trust
Richard Barry SAVA Common Stock Purchase 7.17% $108,319 $2.29 47,308 707,503 19 Sep 2025 By Trust
Richard Barry SAVA Common Stock Purchase 40.6% $426,424 $2.24 190,633 660,195 18 Sep 2025 By Trust
Patrick J. MD Scannon PhD SAVA Stock Option (Right to Buy) Award 26,500 26,500 23 May 2025 Direct
Robert Eugene Anderson Jr. SAVA Stock Option (Right to Buy) Award 26,500 26,500 23 May 2025 Direct
Pierre Gravier SAVA Stock Option (Right to Buy) Award 26,500 26,500 23 May 2025 Direct
Robert Z. Gussin SAVA Stock Option (Right to Buy) Award 26,500 26,500 23 May 2025 Direct
Claude Nicaise SAVA Stock Option (Right to Buy) Award 26,500 26,500 23 May 2025 Direct
Michael J. O Donnell SAVA Stock Option (Right to Buy) Award 26,500 26,500 23 May 2025 Direct
Eric J. Schoen SAVA Stock Option (Right to Buy) Award 100,000 100,000 17 Apr 2025 Direct
Richard Barry SAVA Stock Option (Right to Buy) Award 350,000 350,000 17 Apr 2025 Direct
Freda Nassif SAVA Stock Option (Right to Buy) Award 100,000 100,000 17 Apr 2025 Direct
Robert Christopher Cook SAVA Stock Option (Right to Buy) Award 100,000 100,000 17 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.